IDDI
30 avenue provinciale
1340 Louvain-la-Neuve
One2Treat
25 boulevard Baudouin 1er
1348 Louvain-la-Neuve
 | marc.buyse@iddi.com |
Marc Buyse is the founder of the International Drug Development Institute (IDDI), CluePoints and One2Treat. He is Associate Professor of Biostatistics at Hasselt University in Belgium. He holds degrees in engineering and statistics from Brussels University (ULB), management from the Cranfield School of Management (Cranfield, UK) and a doctorate in biostatistics from Harvard University (Boston, MA). He was President of the International Society for Clinical Biostatistics, President of the Quetelet Society, and Fellow of the Society for Clinical Trials. He worked at the EORTC (European Organization for Research and Treatment of Cancer) in Brussels and at the Dana Farber Cancer Institute in Boston. His research interests include validation of surrogate endpoints, statistical detection of errors and fraud in clinical trials, and estimation of Net Treatment Benefit using generalized pairwise comparisons.
